MergerLinks Header Logo
Cover Image Sevan Antreasyan
Sevan Antreasyan

Sevan Antreasyan

Partner at Lenz & Staehelin

Lawyer

Deal Bio

Total Deals8
Valued Deals5
Total Value£747M
Avg. Deal Size£149M

Sort

Switzerland
Pharmaceuticals
AcquisitionPrivateMajority
Novimmune (emapalumab And Related Assets)

target

Novimmune (emapalumab And Related Assets)

Swedish Orphan Biovitrum (sobi)

bidder

Swedish Orphan Biovitrum (sobi)

£409m

31 dealmakers

Switzerland
Health Care Services
MajorityAcquisitionPrivatePrivate Equity
SOLVIAS

target

SOLVIAS

Water Street Healthcare Partners

bidder

Water Street Healthcare Partners

value n/a

29 dealmakers

Switzerland
Biotechnology
AcquisitionMinorityPrivatePrivate EquityCross Border
Chord Therapeutics

target

Chord Therapeutics

Omega Funds

bidder

Omega Funds

£12m

15 dealmakers

Switzerland
Electronic Components and Equipment
MajorityCross BorderAcquisitionPrivatePrivate Equity
BLUEBOTICS

target

BLUEBOTICS

ZAPI

bidder

ZAPI

value n/a

18 dealmakers

Switzerland
Software
PrivateCross BorderAcquisitionMinorityPrivate Equity
BEQOM

target

BEQOM

Sumeru Equity Partners

bidder

Sumeru Equity Partners

£230m

43 dealmakers

Switzerland
Online and Social Platforms
Private EquityMajorityAcquisitionDomesticPrivate
Consulcesi Group

target

Consulcesi Group

Gyrus Capital

bidder

Gyrus Capital

value n/a

32 dealmakers

Switzerland
Alternative Fuels
Cross BorderPrivate EquityMinorityVenture CapitalAcquisitionPrivate
TRANSMUTEX

target

TRANSMUTEX

At One Ventures

bidder

At One Ventures

£18m

9 dealmakers

Switzerland
Biotechnology
PrivateMinorityAcquisitionCross BorderPrivate EquityVenture Capital
ASCENEURON

target

ASCENEURON

Novo Holdings

bidder

Novo Holdings

£77m

10 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US